Kang Le

机构：National Heart Lung and Blood Institute · ORCID：0000-0002-1714-2377

发表论文 52 篇 · 总被引 784 次 · h-index 15

代表论文

• Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity (2023 · Blood Advances · 被引 35)
• Anticancer mechanisms on pyroptosis induced by Oridonin: New potential targeted therapeutic strategies (2023 · Biomedicine & Pharmacotherapy · 被引 19)
• Activating pyruvate kinase improves red blood cell integrity by reducing band 3 tyrosine phosphorylation (2024 · Blood Advances · 被引 16)
• Effectiveness and safety of finerenone in diabetic kidney disease patients: a real-world observational study from China (2024 · Renal Failure · 被引 15)
• Research Progress and New Perspectives of Anticancer Effects of Emodin (2023 · The American Journal of Chinese Medicine · 被引 15)
• NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers (2025 · Nature · 被引 13)